eHealth mHealth HealthTech innovations - Marketing Santé innovant
40.2K views | +0 today
Follow
 
Rescooped by Dominique Godefroy from Doctors Hub
onto eHealth mHealth HealthTech innovations - Marketing Santé innovant
Scoop.it!

INTUITIM : un nouvel outil pour le radiologue

INTUITIM : un nouvel outil pour le radiologue | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Intuitim est une jeune spin-off de l’UCL, portée sur les fonts baptismaux en novembre 2012 afin de commercialiser les résultats de travaux de recherche menés pendant 3 ans au sein du laboratoire ICTeam (Information and Communication Technologies, Electronics and Applied Mathematics) de la Faculté des sciences appliquées de l’UCL.

Le projet de recherche a tout d'abord débouché sur la création de la solution Mammo-Note, une application d’annotation normalisée de mammographie, permettant au médecin d’apporter remarques et commentaires en les indiquant simplement, via annotation manuelle à l’écran, en recourant à une codification normalisée, reconnue internationalement (BI-RADS). Selon le type de lésion, le système déclenche des menus contextuels, permettant au spécialiste de documenter son diagnostic en sélectionnant les paramètres et indications dans les menus préparamétrés. Le diagnostic se construit ainsi visuellement, par marquages standardisés.


Via Philippe Marchal
more...
No comment yet.
eHealth mHealth HealthTech innovations - Marketing Santé innovant
Digital, Apps, IoT, devices, AI / DL (...) innovations for Health and Healthcare
Your new post is loading...
Your new post is loading...
Scooped by Dominique Godefroy
Scoop.it!

Google Is Training Machines to Predict When a Patient Will Die

Google Is Training Machines to Predict When a Patient Will Die | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

A woman with late-stage breast cancer came to a city hospital, fluids already flooding her lungs. She saw two doctors and got a radiology scan. The hospital’s computers read her vital signs and estimated a 9.3 percent chance she would die during her stay.

Then came Google’s turn. An new type of algorithm created by the company read up on the woman -- 175,639 data points -- and rendered its assessment of her death risk: 19.9 percent. She passed away in a matter of days.

The harrowing account of the unidentified woman’s death was published by Google in May in research highlighting the health-care potential of neural networks, a form of artificial intelligence software that’s particularly good at using data to automatically learn and improve. Google had created a tool that could forecast a host of patient outcomes, including how long people may stay in hospitals, their odds of re-admission and chances they will soon die.

What impressed medical experts most was Google’s ability to sift through data previously out of reach: notes buried in PDFs or scribbled on old charts. The neural net gobbled up all this unruly information then spat out predictions. And it did it far faster and more accurately than existing techniques. Google’s system even showed which records led it to conclusions.

Hospitals, doctors and other health-care providers have been trying for years to better use stockpiles of electronic health records and other patient data. More information shared and highlighted at the right time could save lives -- and at the very least help medical workers spend less time on paperwork and more time on patient care. But current methods of mining health data are costly, cumbersome and time consuming.

As much as 80 percent of the time spent on today’s predictive models goes to the “scut work” of making the data presentable, said Nigam Shah, an associate professor at Stanford University, who co-authored Google’s research paper, published in the journal Nature. Google’s approach avoids this. "You can throw in the kitchen sink and not have to worry about it,” Shah said.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy

Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Three years after buying a majority stake in Foundation Medicine for more than $1 billion as part of a research and development collaboration, Roche Pharmaceuticals has acquired the rest of the company in a $2.4 billion follow-on deal for the business, which selects cancer treatments for patients based on their genetic profile. It’s the latest in a series of companies Roche has acquired to add services and technology to the Big Pharma’s drug development business, particularly in cancer treatment.

Roche CEO Daniel O’Day said in a news release that his company would continue to preserve Foundation Medicines autonomy to support its innovative approach.

“This is important to our personalized healthcare strategy as we believe molecular insights and the broad availability of high quality comprehensive genomic profiling are key enablers for the development of, and access to, new cancer treatments.”

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

No pharma Grand Prix—again—at Cannes Lions Health, but record number of awards for drugmakers

No pharma Grand Prix—again—at Cannes Lions Health, but record number of awards for drugmakers | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

For the second year in a row, there is no grand prize winner in the pharma category at Cannes Lions Health. The big idea award, called the Grand Prix, eluded the field again , despite a pharma-heavy short list.

But while pharma marketers may be disappointed, they still have plenty of reason to celebrate. Sixteen different pharma companies made the awards shortlist and 10 won gold, silver or bronze Lions. That’s a sharp uptick from last year when only nine were finalists and three picked up awards.

Of those, seven silver or bronze awards went to U.S. efforts for six different drugmakers. 

Boehringer Ingelheim won two Cannes Lions Health statues—a silver and a bronze—both for its Stiolto Respimat print work. Bayer, Takeda, Eli Lilly and Biogen each picked up one silver award, while Novartis nabbed a bronze for its U.S. division and another bronze for its Argentina work. The branded products featured were Xofigo (Bayer), Trintellix (Takeda) and Spinraza (Biogen).

GlaxoSmithKline in China and AstraZeneca in United Arab Emirates were also bronze winners. U.K.-based Mundipharma picked up a gold Lion award, as did medical device company Cochlear in Australia.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Improving Patient Engagement and Satisfaction with Telemedicine Technology

Improving Patient Engagement and Satisfaction with Telemedicine Technology | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
About three years ago, Dr. Alfred Atanda was in southern Delaware, about 100 miles from the Nemours/Alfred I. duPont Hospital for Children, where he is a pediatric orthopedic surgeon. Atanda happened to stop in a beach shop owned by the father of a recent post-op patient, where he learned that the patient was having trouble with his brace.

Atanda and the patient’s father called the boy, who was having trouble explaining the problem. So Atanda started an impromptu video chat. He looked at the brace via the video chat, showed the boy how to adjust it, and also asked him about his appetite and other aspects of his recovery.

Driving home, Atanda realized the family had made the same 200-mile drive several times — sometimes for follow-up appointments that were no more than five minutes.

“I couldn’t believe I’d seen him six times in the office — and every time, dad closes the shop, and the son takes off time from school,” he says. The patient had another appointment in two days, but he told the family not to come. This experience helped crystalize the power and value of telemedicine for both patient and doctor convenience.


Improving Patient Satisfaction: Telemedicine Technology Keeps Patients Out of the Office

Telemedicine technology is already at work improving the patient and provider experience in many innovative organizations. At the Cleveland Clinic, the telemedicine program encompasses a wide range of technology — from connected devices to virtual visits to remote imaging transfers — which are used inside the hospital and in a patient’s home, says Dr. Peter Rasmussen, the organization’s medical director of distance health.

more...
No comment yet.
Rescooped by Dominique Godefroy from PATIENT EMPOWERMENT & E-PATIENT
Scoop.it!

Et si les technologies réhumanisaient le monde de la santé ? #hcsmeufr #esante 

Et si les technologies réhumanisaient le monde de la santé ? #hcsmeufr #esante  | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Objets connectés, télémédecine, télédiagnostic... Certains observent avec appréhension la transition numérique du monde de la santé et l'émergence d'un soin trop technologique. Et si c'était l'inverse ? Le point de vue de Cécile Mico, Responsable du développement commercial marché santé chez DXC Technology.

 

Les fabuleux progrès accomplis par la médecine ces dernières décennies ont amené les professionnels de santé à se spécialiser toujours davantage. Parce qu’aucun praticien ne peut maîtriser tout le savoir médical, chacun se spécialise dans un domaine, tandis que la médecine affiche une technicité croissante.

 

Résultat ? Les patients souffrent d’une médecine trop compartimentée, faisant intervenir plusieurs médecins sans qu’aucun d’eux n’ait une vision globale de leur état. Cette hyperspécialisation affecte aussi le dialogue entre le soignant et le patient : comment savoir si l’on doit confier tel ou tel symptôme à un médecin ou à un autre ? Comment comprendre le jargon médical ?

 

L’arrivée des nouvelles technologies va non seulement modifier en profondeur la relation entre patients et soignants, mais aussi la réhumaniser.


Via Lionel Reichardt / le Pharmageek
more...
IZYCARDIO's curator insight, June 20, 6:51 AM

Ou comment les outils de télémédecine vont permettre aux patients de redevenir acteurs de leur santé tout en accordant plus de temps aux médecins.

 

Ces outils, et services, vont favoriser les échanges d'informations entre les acteurs de la santé ainsi qu'aider à l'éducation et à la responsabilisation du patient.

 

Espérons que le numérique encouragera le développement des patients experts, qui peuvent devenir d'importants acteurs du parcours de soin.

Scooped by Dominique Godefroy
Scoop.it!

Telehealth could support caregiver experience but quality evidence is lacking

Telehealth could support caregiver experience but quality evidence is lacking | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Previous studies on the impact telehealth tools had on caregiver support showed potential benefits, but evidence of quality is lacking. A new systematic review on the topic was published June 18 in the Journal of Medical Internet Research.

The number of published works exploring the impact of telehealth on patients' quality of care has increased, but there are few studies examining telehealth’s effect on caregivers of cancer patients. In this review, researchers analyzed published articles to identify telehealth’s feasibility in supporting cancer caregivers.

“Even though much has been done concerning patient empowerment, more attention needs to be paid to the effects and support of telemedicine on family caregivers and on how promising eHealth programs are in responding to their needs,” wrote first author Chiara Marzorati, MSc, and colleagues. “Despite caregivers’ requests for provision of support and information competence, a recent meta-review on the effects of eHealth for cancer patients and caregivers concluded that there is indeed a paucity of systematic reviews on this topic and that Web-based interventions focused on family members are still an unexplored area.”

Researchers searched for relevant published works in a variety of databases including Web of Science, Cochrane Library, PubMed, Scopus, CINAHL, MEDLINE, EMBASE, Google Scholar and PsycINFO. A total of 24 studies were included in the analysis, 21 of which highlighted the patient-caregiver relationship.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Deloitte integrates patient engagement platform with Apple frameworks

Deloitte integrates patient engagement platform with Apple frameworks | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Deloitte has integrated its ConvergeHEALTH Patient Connect tool, a patient engagement platform, with Apple HealthKit, CareKit and ResearchKit.

Deloitte’s life sciences clients use Patient Connect to support their patients with diseases like diabetes and cancer.

Via email, Brett Davis, ConvergeHEALTH general manager and principal at Deloitte, discussed the industry’s shift to patient-centered care. The movement traditionally wasn’t possible from a data perspective, as consumers weren’t given power over their own data. But that’s changing because of the work of Apple and other vendors, he noted.

“As part of the Apple enterprise alliance we announced in 2016, we created a first-of-its-kind Apple practice to focus on transforming industries,” Davis said.

Initially announced in the fall of 2016, the practice includes a group of app developers who focus on healthcare-specific apps.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Patents hold clues about Apple, Amazon, Google and Microsoft plans for healthcare

Patents hold clues about Apple, Amazon, Google and Microsoft plans for healthcare | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Many eyes are watching the likes of Amazon, Apple, Google, Microsoft and other tech stalwarts for some kind of signal about their healthcare intentions. While some moves are already out in the open, such as Apple Health Records and Amazon Web Services expressing interest in longitudinal health records and analytics, the companies also have patents that potentially foretell the future.

As of Jan. 23, Amazon-owned 7,096 U.S. patents, according to the United States Patent and Trademark Office.

In addition, Amazon Technologies, Inc., had filed and published 870 patent applications in the U.S. as of Jan. 23, and Amazon.com, Inc., had filed and published 16 patent applications.

Amazon has been granted patents for thousands of inventions spanning one-click buying, drones, virtual-reality mirrors and Alexa, the company’s AI–powered voice assistant.

Google, for instance, – with 186 patents – focused mostly on investments for DeepMind, its artificial intelligence technology, and also on Verily, its healthcare and disease research entity among its 186 patents, according to the new Kalorama report.

Apple filed 54 patents to turn its iPhone into a medical device that can monitor biometric data such as blood pressure and body fat levels and to develop algorithms to predict abnormal heart rates. Microsoft filed 73 patents based on expanding its AI capabilities and developing monitoring devices for chronic diseases.

Such innovations have encouraged biopharma, medtech and providers to partner with these tech giants to boost digital healthcare, Kalorama noted.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Publicis executive Matt McNally takes on rebuilding as Outcome Health CEO

Publicis executive Matt McNally takes on rebuilding as Outcome Health CEO | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

As it navigates beyond a year of rough waters, point-of-care marketer Outcome Health has tapped Publicis veteran Matt McNally to take the helm as CEO.

Currently president and chief media officer at Publicis Health, McNally will fill the void created earlier this year by co-founder Rishi Shah, who stepped aside in a legal settlement with investors. Shah remains a director on Outcome’s board.

McNally will join Outcome officially on June 25. His appointment comes at a key juncture for the company, which is rebuilding after months of investor lawsuits, internal investigations and critical media reports. 

Shah and co-founder Shradha Agarwal stepped aside from day-to-day management in January in a deal with investors who had sued over allegations of misconduct. That settlement included a $159 million payout from the co-founders and other investors to reduce Outcome's debt and build up its technology.

“Matt’s advertising experience has taught him firsthand the power of POC and reaching patients during the most special and critical moments of care,” COO Nandini Ramani in an internal message to the Outcome staff announcing McNally’s hire. “He has been familiar with Outcome Health for years as an agency partner, and he jumped at the opportunity to lead our company because he recognizes the monumental opportunity we are poised to seize.”

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Diagnostic du mélanome: l'intelligence artificielle supérieure à l'homme dans une étude

Diagnostic du mélanome: l'intelligence artificielle supérieure à l'homme dans une étude | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Un algorithme de "deep learning" (apprentissage profond) utilisant un réseau de neurones artificiels à convolution s'est montré plus performant, dans une étude, que la plupart des dermatologues pour diagnostiquer des mélanomes.

Face à l'incidence croissante du mélanome, cancer cutané à mauvais pronostic, le dépistage précoce et la prévention sont essentiels, rappellent le Pr Holger Haenssle de l'université de Heidelberg et ses collègues allemands, américains et français dans un article publié dans les Annals of Oncology.

Mais l'examen au dermatoscope nécessite un oeil exercé et depuis quelques années, les méthodes d'analyse automatique des images se développent comme outil d'aide au diagnostic pour permettre un diagnostic précis et reproductible. Cependant, cette approche reste liée à des critères dépendants de l'oeil humain (couleur, morphologie, régularité...).

En 2017, dans une lettre publiée par Nature, une équipe américaine de l'université de Stanford avait rapporté le développement d'un algorithme de deep learning utilisant un réseau de neurones artificiels à convolution pour apprendre à classer des images de cancers cutanés, avec une performance supérieure à 21 dermatologues entraînés.

L'intelligence artificielle (IA) permet de déconstruire l’image à l'échelle du pixel et utilise ces informations supplémentaires pour distinguer les différentes lésions cutanées.

Cette fois, le Pr Haenssle et ses collègues ont modifié l'algorithme Inception v4 de Google pour développer un réseau de neurones artificiels à convolution, pré-entraîné avec plus de 100.000 images de lésions cutanées diagnostiqués, afin de classer les lésions mélanocytaires en particulier.

Une collection de 100 clichés dermatoscopiques a ensuite été soumise à l'algorithme pour classer les lésions en "bénignes" ou "malignes". Les résultats ont ensuite été comparés aux diagnostics établis par un groupe de 58 dermatologues de 17 pays (17 avec moins de deux ans d'expérience en analyse dermatoscopique, 11 étant bien entraînés avec deux à cinq ans d'expérience et 30 experts avec au moins cinq ans d'expérience).
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

The Big Trends Transforming Pharma

The Big Trends Transforming Pharma | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
For all the world’s afflictions, the 21st century has been a relative triumph. Since 2000 infant mortality rates have dropped by half, to 5.6m. Life expectancy has reached 71, an increase of five years, and HIV-related deaths have fallen dramatically.

From smartphones to the looming prospect of driverless cars, the lightning pace of technological progress also shows no sign of slowing down.

And as tech and medicine converge, the pharmaceutical industry is at the forefront of this change.

How will this shape pharma’s future? We asked the industry’s thought leaders to weigh in on this brave new world.

Find your niche
Pharma’s inroads into personalized healthcare are animating expectations far and wide. The principle driver of this evolution is pharma’s vast data pools, says Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals.

“I am convinced that the vast data sets today in healthcare will help us to determine much faster and more efficiently the next best intervention for each individual patient. This will be enabled by data science, machine learning and artificial intelligence.”

Personalization tools are a major boon to physicians and the way they conduct their practice, says Christi Shaw, Senior Vice President and President, Lilly Bio Medicines, Eli Lilly. Doctors have a deep well of data at their disposal and can provide patients with a much more tailored treatment plan than ever before, she says. Greater personalization could also drastically reduce the risk of a misdiagnosis, she adds.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Findings in science, health reporting often overstated on social media

Findings in science, health reporting often overstated on social media | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Spin. Clickbait. Exaggerated headlines. The rise of social media such as Facebook and Twitter has changed how health-related research and news is presented to audiences around the world, and it is not unheard of for researchers and reporters to overstate the findings of a study.

To better understand this issue, a May 30, 2018 study in PLOS One took a detailed look at the 50 most-shared academic journal articles linking any exposure with a health outcome, and media stories that covered those articles. The multidisciplinary research team was led by Noah Haber, who recently completed his Sc.D. in health economics in the Department of Global Health and Population at Harvard T.H. Chan School of Public Health. They assessed the studies’ strength of causal inference, or whether the study could determine that the exposure itself changed the health outcome, using a novel systematic review tool. They then compared them with the strength of causal language used to describe results in both academic journal articles and media articles.

The study found that 34 percent of the academic studies reviewed used language that reviewers considered too strong given their strength of causal inference, and 48 percent of media articles used stronger language than their associated academic articles. Moreover, 58 percent of media articles inaccurately reported the question, results, intervention, or population of the academic study. The team is now researching how academia, media, and social media contribute to this issue, and interventions to help fix it.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Joe, le robot qui aide les enfants à prendre leurs médicaments

Joe, le robot qui aide les enfants à prendre leurs médicaments | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
La jeune entreprise lyonnaise Ludocare a imaginé le robot compagnon Joe, qui aide de façon ludique les jeunes patients asthmatiques à mieux observer leurs traitements pour en améliorer l'efficacité. Il est en bêtatest dans une vingtaine de familles.

Selon les médecins, trois quarts des hospitalisations d'enfants asthmatiques - ils sont 700.000 en France - pourraient être évitées si les médicaments étaient pris correctement, le taux de mésusage dépassant 80 %. Pour ces jeunes malades qui n'aiment pas se soigner, la start-up lyonnaise Ludocare a imaginé et développé Joe, un robot compagnon en forme de réveil. Il les aide à respecter l'observance de leur traitement en sonnant à l'heure de la prise, mais surtout en les motivant avec des récompenses. L'assiduité est gratifiée par une histoire, une anecdote historique ou scientifique, une devinette... enregistrées par un acteur. Joe remplit aussi un rôle pédagogique avec des animations de vulgarisation scientifique sur le médicament et des conseils pour une bonne administration.

Le programme d'intelligence artificielle s'adapte aux préférences de l'enfant et à son âge, évoluant avec lui. La base de données médicales, supervisée par l'un des trois associés, Thierry Basset, pharmacien biologiste, contient les références de 10.000 médicaments. « Car les petits asthmatiques sont souvent multimédicamentés », constate Elodie Loisel, présidente et cofondatrice de Ludocare, ingénieur en physique de formation.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Next-gen medical devices: Security, AI, rethinking design for patient experience

Next-gen medical devices: Security, AI, rethinking design for patient experience | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Medical devices are proliferating throughout the healthcare landscape, especially with the advent of the Internet of Things and the myriad new products that come with it.

The medical device arena is undergoing a lot of change, in fact, as new technologies and calls for greater security push manufacturers to upgrade their products — and the next generation of medical devices could see many new features and functions.

As medical devices continue evolving, the top health IT areas manufacturers and hospitals will be ramping up include security, clinical workflow integration, data management automation and patient experience.


Device security a key priority

It’s no secret that medical device security has become a key priority across the industry. The U.S. Food and Drug Administration in mid-April released the Medical Device Safety Action Plan, with the goal of making devices safer.

Similar to how computer networks are vulnerable to security issues, exposing medical device vulnerabilities could put patients at risk, compromise how a medical device functions or allow an unauthorized user to access a provider’s network, said John Schoew, a managing director at consulting giant Accenture.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Voice Search Could Improve Healthcare for Patients and Providers Alike

Voice Search Could Improve Healthcare for Patients and Providers Alike | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Voice assistants are making their way into the healthcare arena, offering patients and providers a wide range of tools and capabilities. 46% of Americans already use voice assistants, and the number is only expected to increase in the coming years.

As the quality of voice recognition software advances, patients and providers can expect to see more of this technology in both healthcare research and treatment. Here’s how voice assistants and voice search have already impacted the industry, and what changes medical marketers can expect to see in the future.
Why Patients Are Using Voice Search

Aside from convenience, voice assistants often a number of advantages for patients. 55% of voice assistant users surveyed said that one of the major reasons they use these applications is to interact with their devices without using their hands. This is especially beneficial for people with disabilities who may have difficulty typing on a smartphone or keyboard. Voice assistants have the potential to remove barriers and give these patients more control over their health.

According to Think with Google, 41% of people who own a voice-activated speaker say it feels like talking to another person. Voice search thus makes accessing medical information less intimidating and more convenient. This aspect may appeal to older patients in particular, who often feel uncomfortable and unprepared to search for health-related information on a tablet or computer. Voice assistants allow them to speak to a device as they would a person, and receive helpful information about their health in real-time.
more...
No comment yet.
Rescooped by Dominique Godefroy from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

The dawn of biohybrid robotics is here.  #digitalhealth

The dawn of biohybrid robotics is here.  #digitalhealth | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

The new field of biohybrid robotics involves the use of living tissue amalgamated with robotic structures. Muscle is one such potential component of these robots, hopefully providing independent energy for movement and function. However, in efforts to integrate living muscle into these machines, there have been problems with the power these muscles exert and their rapid deterioration.  Now, a study from researchers at the University of Tokyo develops a new method which progresses individual muscle precursor cells to fully functioning skeletal muscle tissues. The team state they incorporated these muscles into a biohybrid robot as antagonistic pairs mimicking those in the body and continued muscle function for over a week.  The study is published in the journal Science Robotics.

 

Previous studies show rapid progress in biohybrid robotics with skeletal muscle tissues formed on a flexible substrate enabling various types of locomotion powered by muscle tissue. However, it has been difficult to achieve high levels of both large and long-term actuations of the skeletal muscle tissues because of their spontaneous shrinkage through the course of the tissue culture.  The current study amalgamates skeletal muscle with a robotic substrate to perform task whilst mimicking a human movement.

 

The current study constructs a robotic skeleton on which to install the pair of functioning muscles.  For the living muscle part of the robot the lab used hydrogel sheets containing muscle precursor cells called myoblasts, holes to attach these sheets to the robot skeleton anchors, and strips to encourage the muscle fibers to form in an aligned manner.  Results show that the muscle fibers successfully act as antagonistic pairs in the robot, with one contracting and the other expanding, just like in the body.  Data findings show as they exert opposing forces on each other they don’t shrink and/or deteriorate.


Via Lionel Reichardt / le Pharmageek
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

European Healthcare Innovation & Investment Learning from successes and navigating opportunities

We have heard all about the unstable policy landscape in the U.S., the unprecedented levels of capital pumped into the market and the mega deals - but how much do we really know about the European space?

Who are the most prominent investors actively investing in healthcare in Europe?

What elements of policy and regulation in Europe support and impede scaling of new and novel healthcare approaches?

What are some of the most notable investments and partnerships and what can we learn from them?

Beyond investment what is important in Europe?
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Biotech, Machine Learning and Healthcare in 2020 and 2025

Biotech, Machine Learning and Healthcare in 2020 and 2025 | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
A 2017, report Grand View Research projects the global biotechnology market is expected to reach USD 727.1 billion by 2025. In 2017, the biotech sector has a total market value of US $370 billion.

Global health care spend projected to reach $8.7 trillion by 2020 according to Deloitte. % of GDP spent on health care should also rise slightly, from an estimated 10.4 % in 2015 to 10.5 % in 2020. By 2020, 50 percent of global health care expenditures – about $4 trillion – will be spent on three leading causes of death: cardiovascular diseases, cancer and respiratory diseases.

Key growth drivers will include regenerative medicine and genetics in diagnostics. Many companies focusing on the development of regenerative therapies will drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. Machine learning will be used in order to understand individual cancer cases, while recommending clinical trials.

Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

AI in Pathology - Use Cases in Slide Imaging, Tissue Phenomics, and More

AI in Pathology - Use Cases in Slide Imaging, Tissue Phenomics, and More | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

AI and machine learning software are beginning to integrate themselves as tools for efficiency and accuracy within pathology. According to a March 2018 digital pathology report produced by Allied Market Research, such software enables the “procurement, management and interpretation” of information and can be applied to multiple functions within the field of healthcare.

In addition to providing functional support for practitioners, students and even patients, interest in applied AI is garnering growing profits; the global market for this technology was valued at more than $3.3 million in 2016, and researchers predict this total will rise to $8.6 million by 2026.

Software is being developed by startups–often in tandem with prominent educational institutions or large hospital research laboratories, addressing different diseases and conditions, most notably forms of cancer. Real-world applications include, but are not limited to:

- Intraoperative diagnosis
- Training
- Primary diagnosis
- Disease prevention
- Manual and semi-quantitative review of immunohistochemistry (IHC)
- Diagnostic consultation and decision support
- Clinical research

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

The downside of healthcare's hottest buzzword: AI

The downside of healthcare's hottest buzzword: AI | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Artificial intelligence and the Internet of Things continue to come up in healthcare discussions and at prominent medical conferences and events. A new report from Accenture found that while executives are taking a keen interest in these technologies, there are some crucial issues to keep in mind before implementing them.

Accenture’s Digital Health Tech Vision 2018 report includes responses from 100 healthcare executives and directors at companies with annual revenues of at least $500 million.

According to the survey, 77 percent of respondents said they anticipate investing in IoT and smart sensors this year. Fifty-three percent expect to invest in AI systems. 

Plus, 80 percent believe that within the next two years, artificial intelligence will work next to humans in their organization.

But it’s not all perfect. Eighty-one percent of surveyed executives said they aren’t prepared to face the societal and liability issues that may require them to explain their AI’s decisions and actions. That’s why 73 percent said they plan to develop internal ethical standards for AI to make sure their technology acts responsibly. That’s probably a good idea, given that 24 percent of executives said they have been the target of adversarial AI behaviors, including bot fraud or falsified location data.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Geofencing: The latest data privacy issue facing healthcare

Geofencing: The latest data privacy issue facing healthcare | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The healthcare industry got a loud introduction to geofencing marketing recently. The headlines were driven by a law firm targeting individuals going to an emergency room. In particular, the ads attempted to lure individuals into a personal injury suit. The type of action that would be sure to draw lines as personal injury is often a disfavored side of the law.

Naturally, the revelation that location could be used for targeted advertising created the usual rush of questioning whether the law firm violated HIPAA. The answer is almost certainly no since the law firm is probably not subject to HIPAA in any form. In the reported instance, the law firm was a personal injury firm, which means it wanted to represent the patients. If the law firm represents the patients, individuals are not covered by HIPAA with regard to their own information. Additionally, the firm was advertising for its own benefit and not for the benefit of the hospital or any other healthcare provider. As such, the law firm is outside the HIPAA regulatory scheme. However, there are a lot of questions to consider when it comes to geofencing and healthcare.

The first question to address is what does geofencing actually mean? It is the process of establishing an artificial perimeter around a specified location using either global positioning (GPS) or radio frequency identification (RFID). Once the geographic boundary is established, the entity or individual running the campaign can set “triggers” that will result in a certain action occurring when a device enters the identified area. In many instances, the action is to push an advertisement when a web browser is opened or otherwise generate targeted ads based. The content of the ads will be determined by the entity or individual running the campaign.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Medical devices for global issues win Wireless Innovation Project

Medical devices for global issues win Wireless Innovation Project | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
First place was awarded to Smart, a point-of-care platform which provides remote diagnostic testing targeting sickle cell disease and malaria. The company was awarded $300,000 for its technology, which diagnoses, tracks and monitors sickle cell disease (SCD) and malaria patients in low resource communities. The system uses two integrated SCD and malaria diagnostic devices to provide affordable remote testing and help facilitate local and national responses to epidemics.

A second place prize of $200,000 was awarded to cerVIA, an affordable, accurate and accessible cervical cancer screening tool. The device is designed to improve screening accuracy through simple imaging and machine learning through an Android device. The device aims to allow healthcare workers and doctors to easily validate their screening and detect early warning indications of cervical cancer.

It’s estimated that SCD affects around 25 million people and that 50-80% of infants born with SCD in Africa die before the age of five. More so, 3.4 billion are at risk of malaria and there are nearly half a million deaths every year across the world due to the disease.

Cervical cancer is estimated to kill 266,000 women every with a staggering 85% of cases occurring in developing countries where quality screening options are lacking.

Smart and CerVIA were chosen from eight finalists announced in April. The winners will receive their grants over a course of three years, as well as support and guidance to advance their products to market.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Loi bioéthique : quelle sera la place des neurosciences dans le monde de demain ?

Loi bioéthique : quelle sera la place des neurosciences dans le monde de demain ? | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
C'était le premier exercice du genre organisé par le Comité consultatif national d'éthique (CCNE) : une vaste consultation des citoyens, des associations et des sociétés savantes menée partout en France dans la perspective de la révision des lois de bioéthique prévue dans le courant de l'année 2019. Plus de 21.000 personnes ont participé aux quelque 270 débats organisés un peu partout en France, près de 65.000 contributions sur le site internet dédié... Le rapport de synthèse de cette grande consultation (qui devrait nourrir la réflexion du CCNE dont l'avis officiel sera publié à l'automne 2018) a été publié mardi 5 juin 2018. Certains thèmes ont été largement médiatisés : la médecine génomique, les recherches sur l’embryon, l’intelligence artificielle... D'autres, au contraire, ont moins fait parler d'eux, comme les neurosciences. Pourtant, les progrès réalisés dans ce domaine suscitent à la fois profondes inquiétudes et espoirs extraordinaires. Et les questions philosophiques et éthiques sont nombreuses : jusqu’à quel point est-il acceptable de modifier notre cerveau ? Quelles limites poser ? Les participants au débat, qui ne sont pas nécessairement des experts en neurosciences, ont exprimé leur opinion lors de cette grande consultation citoyenne. Synthèse des débats avec Catherine Vidal, neurobiologiste et membre du comité d’éthique de l'Inserm.


"Le rêve d’une humanité qui vivra 200 ans à travers une hybridation entre hommes et robots ne trouve pas d’échos favorables"

more...
No comment yet.
Rescooped by Dominique Godefroy from PATIENT EMPOWERMENT & E-PATIENT
Scoop.it!

Ignorance is not bliss: why we need more empowered patients  #esante #hcsmeufr #digitalhealth

Ignorance is not bliss: why we need more empowered patients  #esante #hcsmeufr #digitalhealth | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Shared decision-making should become a mandatory part of training for all healthcare professionals to improve collaboration with their patients, save the NHS billions, and ultimately improve patient outcomes, say Aseem Malhotra and Sue Bailey.

 

At 55 years old, patient X was very active but overweight with a body mass index of 28 and waist measurement of 38 inches. He had been a Virgin Atlantic international airline pilot for 14 years, but then he suffered a non–ST-elevation myocardial infarction in December 2014.

 

Coronary angiography revealed a sub-totally occluded circumflex artery for which he underwent coronary stenting. He was prescribed the standard cocktail of medications following acute coronary syndrome — aspirin 75mg, clopidogrel 75mg (for one year post-stent insertion), bisoprolol 2.5mg, ramipril 2.5mg and atorvastatin 80mg — and discharged.

 

He was then contraindicated to fly as a commercial pilot and went back to regular activities, but approximately one year later he started to experience a number of disabling and persistent symptoms, namely extreme fatigue, muscle aches, memory disturbance and erectile dysfunction.

Attributing this to his statin medication (Pfizer’s own leaflet states 1 in 10 may suffer these side effects), patient X stopped his atorvastatin 80mg and within weeks he noticed a marked improvement in his quality of life “in every respect”.


Via Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Dominique Godefroy from PHARMACY, PHARMACIST, RETAIL - PHARMACIE, PHARMACIEN, DISTRIBUTION
Scoop.it!

Captain Pharma - Un nouveau modèle de pharmacie ?  #esante #hcsmeufr 

Captain Pharma - Un nouveau modèle de pharmacie ?  #esante #hcsmeufr  | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

C’est un nouveau positionnement de pharmacie qui voit le jour avec Captain Pharma, dont le site internet vient de sortir . Derrière ce super héros en forme de gélule, se trouve une offre innovante développée par la Pharmacie Santé Service. Sa mission : améliorer l’observance des patients, en leur apportant la meilleure expérience. Et c’est à travers une image de marque décalée et assez éloignée des codes traditionnels de la pharmacie que l’officine présente son offre.

 

Mais concrètement, que propose Captain Pharma ? Tout d’abord, il faut comprendre à qui s’adresse ce service : aux patients chroniques, à domicile, qui ont des difficultés à se déplacer ou à prendre correctement leur traitement. C’est un choix stratégique original, lorsque le consensus des professionnels indique que le principal axe d’innovation et de développement est « hors ordonnance ».


Via Lionel Reichardt / le Pharmageek
more...
No comment yet.